In vitro studies of SNS-032 (BMS-387032) alone or in combination with cytarabine, induced AML cell cytotoxicity through inhibition of CDK2, CDK7, and CDK9 transcription, resulting in the attenuation of RNA Pol II-mediated transcription (156). The gene discussed is CDK9; the disease is acute myeloid leukemia.